BPL-001 series (Redx Pharma)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameBPL-001 series (Redx Pharma)
Drug Alias NameBPL-001 series (Bradford Pharma)HMG CoA reductase inhibitors (Bradford Pharma)HMG CoA reductase inhibitors (Redx Pharma)BPL-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHMG-CoA reductase inhibitors
TargetsHMG-CoA reductase
Therapy Area/IndicationsCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBradford Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBradford PharmaRedx Pharma Plc
Active IndicationsN/A
Inactive IndicationsCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A